Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT01785849
What this trial is testing

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 508
Post-approval studies (Phase 4)Study completedNCT00891813
What this trial is testing

Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose

Who this might be right for
Secondary HyperparathyroidismRenal Insufficiency, ChronicParathyroid Hormone+2 more
Abbott 100
Early research (Phase 1)Study completedNCT02054572
What this trial is testing

Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis

Who this might be right for
Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis
Amgen 6
Testing effectiveness (Phase 2)Study completedNCT00667576
What this trial is testing

Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis

Who this might be right for
Chronic Kidney Disease on HemodialysisSecondary Hyperparathyroidism
Abbott 153
Large-scale testing (Phase 3)Study completedNCT01788046
What this trial is testing

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 515
Testing effectiveness (Phase 2)Study completedNCT00113945
What this trial is testing

Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)

Who this might be right for
End Stage Renal Disease
Amgen 360
Not applicableStudy completedNCT01401478
What this trial is testing

Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation

Who this might be right for
Secondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 86
Large-scale testing (Phase 3)Study completedNCT01785875
What this trial is testing

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 891